Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
about
Adaptive immunity and atherosclerosis: mouse tales in the AJPCyclosporine A impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretionImmunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesisModulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J miceThe role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathyChronic alcohol feeding inhibits atherogenesis in C57BL/6 hyperlipidemic mice.Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic dietCD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury.Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins.The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.Immunology of atherosclerosis: the promise of mouse models.Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient miceEnhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.
P2860
Q27023345-F06C3C25-B5B7-4B55-BB84-5761DFDB659DQ27309230-3BE1CFF1-A8AD-4468-A9F3-EC1010A0F995Q34737721-3F9A68E9-EC57-4749-836A-0201FC26D683Q35591762-067B2892-CAB8-4655-92F8-CC96EF165B64Q35792034-8B9F2F7B-5173-4A4F-B5B8-16548D1A2DCFQ35796013-DD5F5B75-89A1-40EF-9BC2-50FD79381E73Q35796500-3483D2BD-3929-4658-89FE-BEFC9133EF2CQ35824745-77281477-BE32-4E84-8FD4-00AE88190D88Q35834095-D922EB33-E405-4568-A8CA-8B50DEDED9E9Q36438422-4854F62D-1213-410C-A346-A152B358E92AQ37372718-00516C4C-4D96-4085-9728-244190C9470BQ41029708-0BDDEADF-984D-4B48-B94A-C8DD41CB1523Q42803118-9B128996-A3C4-463C-B01C-FCAE00C3D164Q42930079-6DBA8A6B-F644-4B66-9771-9101A388666BQ42992508-04FF7703-8E57-4105-A139-C0CA1167C61F
P2860
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
@ast
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
@en
type
label
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
@ast
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
@en
prefLabel
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
@ast
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
@en
P2860
P1476
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
@en
P2093
P2860
P304
P407
P577
1993-06-01T00:00:00Z